L04AC Interleukin inhibitors Interleukin inhibitors 白细胞介素抑制剂 白血球介素抑制劑 L4
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 來源:維基百科(中文轉繁體) · CC BY-SA 4.0 (derived zh-Hant)
ATC level L4 · Search this class · Consumer categories
Active ingredients in this class
37 active ingredients 37 principios activos 37 个活性成分 37 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Secukinumab
L04AC10active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES TW EU · discontinued MX · unknown HK - Ustekinumab
L04AC05active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Tocilizumab
L04AC07active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES TW EU · discontinued MX · unknown HK - Guselkumab
L04AC16active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Risankizumab
L04AC18active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES TW EU · discontinued MX · unknown HK - Ixekizumab
L04AC13active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES TW EU · discontinued MX · unknown HK - Siltuximab
L04AC11active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG CN ES TW EU · unknown HK - Tildrakizumab
L04AC17active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Basiliximab
L04AC02active US GB CA SG CN · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA SG CN TW EU · discontinued MX · unknown AU HK - Bimekizumab
L04AC21active US GB CA AU ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU ES MX TW EU · unknown HK - Canakinumab
L04AC08active US GB CA ES TW · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA ES TW EU · unknown AU MX HK - Satralizumab
L04AC19active US GB CA SG ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG ES TW EU · unknown AU HK - Mirikizumab
L04AC24active US GB CA ES MX · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA ES MX TW EU · unknown AU - Spesolimab
L04AC22active US GB CA SG TW · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA SG TW EU · unknown AU HK - Brodalumab
L04AC12active US GB CA ES TW · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB CA ES TW EU · unknown HK - Sarilumab
L04AC14active US GB CA ES EU · and 2 more y 2 más 另有 2 个 另有 2 個
active US GB CA ES EU · unknown HK - Anakinra
L04AC03active US GB CA AU ES · and 1 more y 1 más 另有 1 个 另有 1 個
active US GB CA AU ES EU - Daclizumab
L04AC01active GB · and 4 more y 4 más 另有 4 个 另有 4 個
active GB · discontinued CA · withdrawn EU - Daclizumab Beta
L04AC01discontinued CA · and 2 more y 2 más 另有 2 个 另有 2 個
discontinued CA · withdrawn EU - Rilonacept
L04AC04active US · and 2 more y 2 más 另有 2 个 另有 2 個
active US · withdrawn EU - 托珠单抗
L04ACactive CN
active CN - 佩索利单抗
L04ACactive CN
active CN - 乌司奴单抗
L04ACactive CN
active CN - 古塞奇尤单抗
L04ACactive CN
active CN - Espesolimab
L04AC22active ES
active ES - 阿那白滞素
L04ACactive CN
active CN - 抗CD25人源化单克隆抗体
L04ACactive CN
active CN - Basilixmab
L04AC02active ES
active ES - 依奇珠单抗
L04ACactive CN
active CN - 替瑞奇珠单抗
L04ACactive CN
active CN - 赛立奇单抗
L04ACactive CN
active CN - 比奇珠单抗
L04ACactive CN
active CN - 布罗利尤单抗
L04ACactive CN
active CN - 夫那奇珠单抗
L04ACactive CN
active CN - 萨特利珠单抗
L04ACactive CN
active CN - 利纳西普
L04ACactive CN
active CN - Icotrokinra Containing Product
L04AC28discontinued ES
discontinued ES
By dosage form, across markets
Only ingredients with a recorded ATC class are listed (6,009 of 12,637).